<DOC>
	<DOCNO>NCT00908076</DOCNO>
	<brief_summary>The purpose study determine Amitiza ( lubiprostone ) , drug proven safe effective chronic constipation , also improve constipation symptom Parkinson 's Disease patient . We also evaluate impact drug change bowel movement consistency , quality life motor symptom .</brief_summary>
	<brief_title>Amitiza Constipation Associated With PD ( Parkinson 's Disease )</brief_title>
	<detailed_description>Parkinson 's disease ( PD ) affect one million people United States . It common neurological condition clinically define rigidity ( muscle stiffness ) , bradykinesia ( slowness movement ) tremor . Parkinson 's Disease , however , reveals numerous non-motor symptom underemphasized . Problematic symptom include vary degree dementia , psychosis , diminish assertiveness confidence , general fatigue , excessive daytime sleepiness , problem blood pressure , sweating , bladder , common yet difficult define sense `` feeling well '' . A commonly miss symptom Parkinson 's patient constipation . Constipation difficult treat current medication available many ineffective . Levodopa dopamine agonist drug useful motor symptom Parkinson 's Disease effect constipation . Laxatives enemas provide limited relief bothersome side effect . Even few drug study target constipation problem specifically Parkinson 's Disease population . Lubiprostone ( AMITIZA ) new medication study general population treatment chronic constipation . It show safe effective medication side effect . Lubiprostone yet study Parkinson 's Disease population . We hope show medication safe effective constipation PD patient well .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Lubiprostone</mesh_term>
	<criteria>1 . Subjects must diagnose PD accord conventional criterion . 2 . Subjects must report constipation fulfill Rome III criteria19 chronic constipation : least 3 month , last 6 month two follow : . Less 3 SBM 's per week ii . Straining defecation 25 % time iii . Lumpy hard stool defecation 25 % time iv . Sensation incomplete evacuation defecation 25 % time v. Sensation anorectal obstruction blockage defecation 25 % time vi . Use manual maneuver facilitate defecation 25 % time 3 . Patients encourage use lubiprostone constipation . If use agent need record use diary ; BM occur within 24 hour agent use record , count SBM . 4 . Patients patient ' caretaker ( ) / legal guardian must able read , understand , accurately record data diary guarantee full participation study . 5 . Patients age 50 must colonoscopy sigmoidoscopy within 5 year . 6 . Patients patient 's caretaker ( ) /legal guardian must willing able provide inform consent beginning study . Evidence structural abnormality gastrointestinal tract diseases/conditions affect bowel transit include gastric , small bowel colonic resection ( appendectomy , cholecystectomy , benign polypectomy allow ) ; history colon cancer , history inflammatory bowel disease ( Crohn 's disease ulcerative colitis ) ; insulindependent diabetes mellitus , history Hirschsprung 's disease , progressive systemic sclerosis ( scleroderma ) , anorexia nervosa ; diseases condition opinion investigator significantly affect bowel transit . Subjects constipation secondary document cause . Planned use drug agent pretreatment phase onward affect gastrointestinal motility and/ prescription include laxative include stool softener ( patient experience significant constipation may use laxative rescue medication need ) ; antidiarrheal ( case significant diarrhea loperamide may use need ) ; antacid contain magnesium aluminum salt ( calcium contain one allow ) ; anticholinergic , antispasmodic agent ( e.g. , Librax , Donnatal , dicyclomine ) ; erythromycin macrolides ; octreotide ; ondansetron 5HT3 antagonist ; opioids/narcotic analgesic ; prokinetics ( metoclopramide ) ; serotonin reuptake inhibitor tricyclic antidepressant ( allow constant dos least 1 month treatment ) ; calcium antagonist ( allow constant dos least 1 month treatment ) . Subjects significant cardiovascular , liver , lung , renal , psychiatric neurological disease ( include PD ) . Patients previous allergic reaction lack tolerability lubiprostone . Current recent history ( within 12 month ) drug alcohol abuse . Pregnancy breast feed . Fertile woman ( define surgically sterile , &gt; 1 year postmenopausal currently use comply medically approve method contraception ) . Lubiprostone study pregnant woman use pregnancy potential benefit justify potential risk fetus . Women negative pregnancy test begin treatment lubiprostone need practice effective contraceptive measure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>constipation</keyword>
	<keyword>Parkinson 's disease</keyword>
</DOC>